Alkoxyamines: Toward a new family of theranostic agents against cancer

Molecular Pharmaceutics

Volumn 11, Issue 7, 2014, Pages 2412-2419

  Moncelet, Damien ^a   Voisin, Pierre ^a   Koonjoo, Neha ^a   Bouchaud, Véronique ^a   Massot, Philippe ^a   Parzy, Elodie ^a   Audran, Gérard ^b   Franconi, Jean Michel ^a   Thiaudière, Eric ^a   Marque, Sylvain R A ^b   Brémond, Paul ^b   Mellet, Philippe ^a,c  

^a CNRS University Bordeaux Segalen   (France)

^b AIX MARSEILLE UNIV   (France)

^c INSERM   (France)

Author keywords

alkoxyamines; alkyl radicals; apoptosis; cancer; imaging; nitroxides; OMRI; theranostics

Indexed keywords

ALKOXYAMINE DERIVATIVE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; LIPOCORTIN 5; NITROXIDE; PROPIDIUM IODIDE; RADICAL; TROXERUTIN; UNCLASSIFIED DRUG; ALCOHOL DERIVATIVE; ALKOXYL RADICAL; AMINE;

A WAVE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CELLS; CONTROLLED STUDY; CYTOMETRY; CYTOTOXICITY; DRUG SYNTHESIS; ELECTROCONVULSIVE THERAPY; ENZYME ASSAY; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMAGING; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; MINOR (PERSON); MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION; OXIDATIVE STRESS; POLYMERIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAINING; SYNTHESIS; TOXICITY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GLIOBLASTOMA; PROCEDURES; TUMOR CELL LINE;

ALCOHOLS; AMINES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84904011691     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5001394     Document Type: Article

References (28)

1. Trachootham, D.; Alexandre, J.; Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discovery 2009, 8, 579-591
2. Ozben, T. Oxidative stress and apoptosis: impact on cancer therapy J. Pharm. Sci. 2007, 96, 2181-2196
3. Davies, K. J. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress IUBMB Life 1999, 48, 41-47
4. Suntharalingam, K.; Johnstone, T. C.; Bruno, P. M.; Lin, W.; Hemann, M. T.; Lippard, S. J. Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways J. Am. Chem. Soc. 2013, 135, 14060-14063
5. Singh, J.; Petter, R. C.; Baillie, T. A.; Whitty, A. The resurgence of covalent drugs Nat. Rev. Drug Discovery 2011, 10, 307-317
6. Audran, G.; Brémond, P.; Franconi, J.-M.; Marque, S. R. A.; Massot, P.; Mellet, P.; Parzy, E.; Thiaudière, E. Alkoxyamines: a new family of pro-drugs against cancer. Concept for theranostics Org. Biomol. Chem. 2014, 12, 719-723
7. Bertin, D.; Gigmes, D.; Marque, S. R. A.; Tordo, P. Kinetic subtleties of nitroxide mediated polymerization Chem. Soc. Rev. 2011, 40, 2189-2198
8. d value of the initiating alkoxyamine and the importance of the experimental conditions Macromolecules 2006, 39, 5238-5250
9. Brémond, P.; Marque, S. R. A. First proton triggered C-ON bond homolysis in alkoxyamines Chem. Commun. 2011, 47, 4291-4293
10. Brémond, P.; Koita, A.; Marque, S. R. A.; Pesce, V.; Roubaud, V.; Siri, D. Chemically triggered C-ON bond homolysis of alkoxyamines. Quaternization of the alkyl fragment Org. Lett. 2012, 14, 358-361
11. Audran, G.; Brémond, P.; Marque, S. R. A.; Obame, G. Chemically triggered C-ON bond homolysis of alkoxyamines. 5. Cybotactic effect J. Org. Chem. 2012, 77, 9634-9640
12. Johnson, D. H.; Ahmad, R.; He, G.; Samouilov, A.; Zweier, J. L. Compressed sensing of spatial electron paramagnetic resonance imaging Magn. Res. Med. 2013, 10.1002/mrm.24966
13. Lurie, D. J.; Bussell, D. M.; Bell, L. H.; Mallard, J. R. Proton electron double magnetic resonance imaging of free radical solutions J. Magn. Reson. 1988, 76, 366-370
14. Matsumoto, K.; Hyodo, F.; Anzai, K.; Utsumi, H.; Mitchell, J. B.; Krishna, M. C. Brain redox imaging. Methods in molecular biology Methods Mol. Biol. 2011, 711, 397-419
15. Koonjoo, N.; Parzy, E.; Massot, P.; Lepetit-Coiffé, M.; Marque, S. R. A.; Franconi, J.-M.; Thiaudière, E.; Mellet, P. In vivo Overhauser-enhanced MRI of proteolytic activity Contrast Media Mol. Imaging 2014, 10.1002/cmmi.1586
16. Massot, P.; Parzy, E.; Pourtau, L.; Mellet, P.; Madelin, G.; Marque, S.; Franconi, J.-M.; Thiaudière, E. In vivo high-resolution 3D overhauser-enhanced MRI in mice at 0.2 T Contrast Media Mol. Imaging 2012, 7, 45-50
17. Parzy, E.; Bouchaud, V.; Massot, P.; Voisin, P.; Koonjoo, N.; Moncelet, D.; Franconi, J.-M.; Thiaudière, E.; Mellet, P. Overhauser-enhanced MRI of elastase activity from in vitro human neutrophil degranulation PloS One 2013, 8, e57946
18. Sinha, K.; Das, J.; Pal, P. B.; Sil, P. C. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis Arch. Toxicol. 2013, 87, 1157-1180
19. Van Ruijssevelt, L.; Smirnov, P.; Yudina, A.; Bouchaud, V.; Voisin, P.; Moonen, C. Observations on the viability of C6-glioma cells after sonoporation with low-intensity ultrasound and microbubbles IEEE Trans. Ultrason., Ferroelectr., Freq. Control 2013, 60, 34-45
20. Shet, K.; Caia, G. L.; Kesselring, E.; Samouilov, A.; Petryakov, S.; Lurie, D. J.; Zweier, J. L. A novel variable field system for field-cycled dynamic nuclear polarization spectroscopy J. Magn. Reson. 2010, 205, 202-208
21. Fu, D.; Calvo, J. A.; Samson, L. D. Balancing repair and tolerance of DNA damage caused by alkylating agents Nat. Rev. Cancer 2012, 12, 104-120
22. Mellet, P.; Massot, P.; Madelin, G.; Marque, S. R. A.; Harte, E.; Franconi, J.-M.; Thiaudière, E. New concepts in molecular imaging: non-invasive MRI spotting of proteolysis using an Overhauser effect switch PloS One 2009, 4, e5244
23. Bertin, D.; Gigmes, D.; Marque, S. R. A.; Tordo, P. Polar, steric, and stabilization effects in alkoxyamines C-ON bond homolysis: a multiparameter analysis Macromolecules 2005, 38, 2638-2650
24. Grucker, D.; Guiberteau, T.; Eclancher, E.; Chambron, J.; Chiarelli, R.; Rassat, A.; Subra, G.; Gallez, B. Dynamic nuclear polarization with nitroxides dissolved in biological fluids J. Magn. Reson. 1995, 106, 101-109
25. Overall, C. M.; Kleifeld, O. Tumour microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy Nat. Rev. Cancer 2006, 6, 227-239
26. Atkinson, J. M.; Siller, C. S.; Gill, J. H. Tumour endoproteases: the cutting edge of cancer drug delivery? Br. J. Pharmacol. 2008, 153, 1344-1352
27. Law, B.; Tung, C. H. Proteolysis: a biological process adapted in drug delivery, therapy, and imaging Bioconjugate Chem. 2009, 20, 1683-1695
28. Choi, K. Y.; Swierczewska, M.; Lee, S.; Chen, X. Protease-activated drug development Theranostics 2012, 2, 156-178